Goodwin Procter advised Kiro on the deal. Kiro, a developer of a diagnosis platform designed to assist medical examinations, announced its €13.8 million Series A. This financing...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here